Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

2006524 citationsJournal Article

Authors

Ann Olincy · Department of Veterans Affairs

Josette G. Harris

Abstract

An alpha7 nicotinic agonist appears to have positive effects on neurocognition in persons with schizophrenia. Longer trials are needed to determine the clinical utility of this novel treatment strategy.

Topics & Keywords

Nicotinic Acetylcholine Receptors Study Receptor Mechanisms and Signaling Neurotransmitter Receptor Influence on Behavior

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of General Psychiatry

Volume 63, Issue 6, pp. 630-630

DOI: 10.1001/archpsyc.63.6.630

Field-Weighted Citation Impact: 20.80